Pharma CEOs Urge EU to Reform Pricing Policies as U.S. Investments Surge

European pharmaceutical leaders warn that strict price controls and tariff uncertainty are driving billions in R&D and manufacturing investments to the U.S., threatening EU health sovereignty.